{"id":"https://openalex.org/W2380036341","doi":null,"title":"Pharmacology and clinical evaluation of vorinostat,a histone deacetylase inhibitor","display_name":"Pharmacology and clinical evaluation of vorinostat,a histone deacetylase inhibitor","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2380036341","mag":"2380036341"},"language":"en","primary_location":{"id":"mag:2380036341","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZXYZ200903005.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2765031496","display_name":"Zhongguo xin yao zazhi","issn_l":"1003-3734","issn":["1003-3734"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4323253388","host_organization_name":"Chinese Journal of New Drugs Co. Ltd.","host_organization_lineage":["https://openalex.org/P4323253388"],"host_organization_lineage_names":["Chinese Journal of New Drugs Co. Ltd."],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo xin yao zazhi","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081373974","display_name":"FU De-xing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119648","display_name":"Beijing Hospital","ror":"https://ror.org/02jwb5s28","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210119648"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"FU De-xing","raw_affiliation_strings":["Department of Clinical Pharmacology,Beijing Hospital,Beijing 10073,China)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology,Beijing Hospital,Beijing 10073,China)","institution_ids":["https://openalex.org/I4210119648"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5081373974"],"corresponding_institution_ids":["https://openalex.org/I4210119648"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.26644384,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.5522000193595886,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.5522000193595886,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.41359999775886536,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vorinostat","display_name":"vorinostat","score":1.0},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9649999737739563},{"id":"https://openalex.org/keywords/cutaneous-t-cell-lymphoma","display_name":"cutaneous T-cell lymphoma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9599999785423279},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.9800000190734863},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9309999942779541},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.5019999742507935},{"id":"https://openalex.org/keywords/fda-accelerated-approval","display_name":"accelerated FDA approval","score":0.6079999804496765}],"concepts":[{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.9718854427337646},{"id":"https://openalex.org/C2776202225","wikidata":"https://www.wikidata.org/wiki/Q3569101","display_name":"Histone deacetylase inhibitor","level":5,"score":0.8081739544868469},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.6506805419921875},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6225184798240662},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.599475085735321},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5902149081230164},{"id":"https://openalex.org/C63433958","wikidata":"https://www.wikidata.org/wiki/Q1774688","display_name":"Clinical pharmacology","level":2,"score":0.49126380681991577},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45338380336761475},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.24496522545814514},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.12965065240859985},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2380036341","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZXYZ200903005.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2765031496","display_name":"Zhongguo xin yao zazhi","issn_l":"1003-3734","issn":["1003-3734"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4323253388","host_organization_name":"Chinese Journal of New Drugs Co. Ltd.","host_organization_lineage":["https://openalex.org/P4323253388"],"host_organization_lineage_names":["Chinese Journal of New Drugs Co. Ltd."],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo xin yao zazhi","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1968218944","https://openalex.org/W1968568016","https://openalex.org/W2058232002","https://openalex.org/W2336192459","https://openalex.org/W7097056962","https://openalex.org/W1530282402","https://openalex.org/W1481966521","https://openalex.org/W2156771941","https://openalex.org/W2248954893","https://openalex.org/W7015946313"],"abstract_inverted_index":{"Vorinostat,an":[0],"oral":[1],"histone":[2],"deacetylase(HDAC)":[3],"inhibitor,has":[4],"received":[5],"an":[6],"accelerated":[7],"approval":[8],"from":[9],"FDA":[10],"for":[11],"the":[12,37],"treatment":[13],"of":[14,17],"skin":[15],"manifestations":[16],"cutaneous":[18],"T-cell":[19],"lymphoma(CTCL)":[20],"that":[21],"is":[22],"persistent,progressive":[23],"or":[24],"recurrent":[25],"after":[26],"two":[27],"systemic":[28],"chemotherapies.A":[29],"literature":[30],"search":[31],"was":[32],"conducted":[33],"using":[34],"MEDLINE":[35],"with":[36],"key":[38],"word":[39],"Vorinostat.The":[40],"pharmacology,pharmacokinetics,drug":[41],"interactions,clinical":[42],"uses":[43],"and":[44],"safety":[45],"were":[46],"reviewed":[47],"in":[48],"this":[49],"paper.":[50]},"counts_by_year":[],"updated_date":"2025-10-10T17:16:08.811792","created_date":"2016-06-24T00:00:00"}